{"title":"Linguistic cues for automatic assessment of Alzheimer's disease across languages.","authors":"Vassiliki Rentoumi, Evangelos Vassiliou, Nikiforos Pittaras, Admir Demiraj, Manolis Papageorgiou, Dimitra Sali, Athina Papatriantafyllou, Panagiotis Griziotis, Artemis Chardouveli, Konstantinos Pattakos, George Paliouras","doi":"10.1177/13872877251319401","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Most common forms of dementia, including Alzheimer's disease, are associated with alterations in spoken language.</p><p><strong>Objective: </strong>This study explores the potential of a speech-based machine learning (ML) approach in estimating cognitive impairment, using inputs of speech audio recordings.</p><p><strong>Methods: </strong>We develop an automatic ML pipeline that ingests multimodal inputs of audio and transcribed text, mapping speech and language to domain-specific biomarkers optimized for high explainability and predictive ability. The resulting features are fed through a multi-stage pipeline to determine efficient classification configurations.</p><p><strong>Results: </strong>We evaluated the system on large real-world datasets, achieving above 90% and 70% weighted average F1 scores for two-class (AD versus normal controls) and three-class (AD versus mild cognitive impairment versus normal controls) classification tasks, respectively. Model performance remains stable across different population characteristics.</p><p><strong>Conclusions: </strong>The study introduces a robust, non-invasive method for gauging the cognitive status of AD and MCI patients from speech samples, with the potential of generalizing effectively to multiple types of diseases/disorders which may burden language.</p>","PeriodicalId":14929,"journal":{"name":"Journal of Alzheimer's Disease","volume":" ","pages":"13872877251319401"},"PeriodicalIF":3.4000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Alzheimer's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13872877251319401","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Most common forms of dementia, including Alzheimer's disease, are associated with alterations in spoken language.
Objective: This study explores the potential of a speech-based machine learning (ML) approach in estimating cognitive impairment, using inputs of speech audio recordings.
Methods: We develop an automatic ML pipeline that ingests multimodal inputs of audio and transcribed text, mapping speech and language to domain-specific biomarkers optimized for high explainability and predictive ability. The resulting features are fed through a multi-stage pipeline to determine efficient classification configurations.
Results: We evaluated the system on large real-world datasets, achieving above 90% and 70% weighted average F1 scores for two-class (AD versus normal controls) and three-class (AD versus mild cognitive impairment versus normal controls) classification tasks, respectively. Model performance remains stable across different population characteristics.
Conclusions: The study introduces a robust, non-invasive method for gauging the cognitive status of AD and MCI patients from speech samples, with the potential of generalizing effectively to multiple types of diseases/disorders which may burden language.
期刊介绍:
The Journal of Alzheimer''s Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer''s disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer''s disease.